NDVUX
Price
$18.81
Change
-$0.25 (-1.31%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

NDVUX vs VSIAX

Header iconNDVUX vs VSIAX Comparison
Open Charts NDVUX vs VSIAXBanner chart's image
MFS New Discovery Value R4
Price$18.81
Change-$0.25 (-1.31%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
NDVUX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NDVUX vs. VSIAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDVUX is a StrongSell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. NDVUX (3.49B). VSIAX pays higher dividends than NDVUX: VSIAX (2.01) vs NDVUX (1.13). NDVUX was incepted earlier than VSIAX: NDVUX (14 years) vs VSIAX (13 years). NDVUX is a more actively managed with annual turnover of: 30.00 vs. VSIAX (16.00). NDVUX has a lower initial minimum investment than VSIAX: NDVUX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. NDVUX (9.23). VSIAX return over 5 years is better than : 52.83 vs. NDVUX (19.50).
NDVUXVSIAXNDVUX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD7.94015.03153%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.49B63B6%
Annual Yield % from dividends1.132.0156%
Returns for 1 year9.2316.2357%
Returns for 3 years-0.1820.67-1%
Returns for 5 years19.5052.8337%
Returns for 10 years61.08105.6558%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics